Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes.
1/5 보강
[BACKGROUND] Colorectal cancer (CRC) is the third most common digestive cancer, and immunity plays an important role in the development of CRC.
- p-value P<0.0001
APA
Shen G, Wei F, et al. (2025). Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes.. Translational cancer research, 14(9), 5572-5585. https://doi.org/10.21037/tcr-2025-189
MLA
Shen G, et al.. "Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes.." Translational cancer research, vol. 14, no. 9, 2025, pp. 5572-5585.
PMID
41158212 ↗
Abstract 한글 요약
[BACKGROUND] Colorectal cancer (CRC) is the third most common digestive cancer, and immunity plays an important role in the development of CRC. In this study, we aimed to explore immune-related prognostic biomarkers.
[METHODS] We first explored the immune microenvironment and identified a high immune score cluster and a low immune score cluster on the basis of the immune score calculated by single-sample gene set enrichment analysis (ssGSEA). We also explored the differentially expressed genes (DEGs) between the high- and low-immune score groups and utilized weighted gene coexpression network analysis (WGCNA) to explore the gene sets with the highest correlation with prognosis. DEGs between paracancerous and tumor tissues were discovered on the basis of the RNA sequencing results, and immune-related differentially expressed genes (IRDEGs) were obtained by the intersection of the DEGs with the prognosis-related gene sets determined by WGCNA. Least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression (multi Cox) were used to screen risk factors for overall survival in CRC patients, and a risk score model and nomogram were constructed. We also assessed the relationships among immune infiltration, cancer transcription factor targets and risk factors in the prognostic model.
[RESULTS] Based on the immune enrichment, we divided CRC patients into high and low immune score groups, and the low-immune score group had a better survival rate. The brown cluster of WGCNA is associated with prognosis, the hub DEGs between the brown cluster and RNA sequencing, and we explore the 26 genes. Based on hub DEGs, we developed and validated a risk score model, areas under the curve (AUCs) of 1-, 3-, and 5-year survival were 0.75,0.73, and 0.65, indicating good accuracy and the low-risk score group had a better prognosis(P<0.0001). Combined risk score and clinical information, the nomogram also has good prediction value, the AUC for 1-year survival was 0.809, that for 3-year survival was 0.804, and that for 5-year survival was 0.794.
[CONCLUSIONS] Immunogenomic classification can identify different immune statuses of CRC patients and predict survival.
[METHODS] We first explored the immune microenvironment and identified a high immune score cluster and a low immune score cluster on the basis of the immune score calculated by single-sample gene set enrichment analysis (ssGSEA). We also explored the differentially expressed genes (DEGs) between the high- and low-immune score groups and utilized weighted gene coexpression network analysis (WGCNA) to explore the gene sets with the highest correlation with prognosis. DEGs between paracancerous and tumor tissues were discovered on the basis of the RNA sequencing results, and immune-related differentially expressed genes (IRDEGs) were obtained by the intersection of the DEGs with the prognosis-related gene sets determined by WGCNA. Least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression (multi Cox) were used to screen risk factors for overall survival in CRC patients, and a risk score model and nomogram were constructed. We also assessed the relationships among immune infiltration, cancer transcription factor targets and risk factors in the prognostic model.
[RESULTS] Based on the immune enrichment, we divided CRC patients into high and low immune score groups, and the low-immune score group had a better survival rate. The brown cluster of WGCNA is associated with prognosis, the hub DEGs between the brown cluster and RNA sequencing, and we explore the 26 genes. Based on hub DEGs, we developed and validated a risk score model, areas under the curve (AUCs) of 1-, 3-, and 5-year survival were 0.75,0.73, and 0.65, indicating good accuracy and the low-risk score group had a better prognosis(P<0.0001). Combined risk score and clinical information, the nomogram also has good prediction value, the AUC for 1-year survival was 0.809, that for 3-year survival was 0.804, and that for 5-year survival was 0.794.
[CONCLUSIONS] Immunogenomic classification can identify different immune statuses of CRC patients and predict survival.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
- Comparative effectiveness of robotic and video assisted thoracic surgery for lung cancer across key outcomes.
- Tumor cell membrane-camouflaged nanoparticles co-delivering docetaxel and metformin for enhanced synergistic therapy of HER2-positive breast cancer.
- HSP90 co-regulates the formation and nuclear distribution of the glycolytic output complex to promote resistance and poor prognosis in gastric cancer patients.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Single-cell and spatial transcriptome analysis of breast cancer tumor-associated fibroblast heterogeneity and its mediated remodeling of the tumor microenvironment.
- Rare fusion transcript in a refractory adult T-cell lymphoblastic lymphoma.
- Comprehensive Bioinformatics Analysis and Experimental Verification RNF186 Is a Recurrence Signature Gene of Hepatocellular Carcinoma that Promotes Cell Proliferation.
- Revisiting multi-region 16S sequencing in gastric cancer.
- Integrative Single-Cell and Machine Learning Analysis Identifies an EMT-Associated Prognostic Signature for Papillary Thyroid Cancer.
- CD47 promotes mitogen-activated protein kinase and epithelial-to-mesenchymal transition molecular programs to drive prometastatic phenotypes in non-small cell lung cancer.